Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07816471) titled 'RSV, Influenza, and SARS-CoV-2 Outcomes in Severely Immunosuppressed Adults' on Sept. 7.
Study Type: Observational
Primary Sponsor: Hospital Italiano de Buenos Aires
Condition:
Respiratory Syncytial Virus Infections
Immunocompromised Host
Influenza
COVID - 19
Recruitment Status: Not recruiting
Date of First Enrollment: November 1, 2011
Target Sample Size: 350
To know more, visit https://clinicaltrials.gov/study/NCT07816471
Published by HT Digital Content Services with permission from Health Daily Digest....